Flerie
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm… Read more
Flerie (FLERIE) - Total Liabilities
Latest total liabilities as of December 2025: Skr20.30 Million SEK
Based on the latest financial reports, Flerie (FLERIE) has total liabilities worth Skr20.30 Million SEK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Flerie - Total Liabilities Trend (2016–2025)
This chart illustrates how Flerie's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Flerie Competitors by Total Liabilities
The table below lists competitors of Flerie ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coeptis Therapeutics Inc
NASDAQ:COEP
|
USA | $3.26 Million |
|
QSYS
ST:QSYS
|
Sweden | Skr86.79 Million |
|
AstroNova Inc
NASDAQ:ALOT
|
USA | $63.95 Million |
|
E&P Financial Group Ltd
AU:EP1
|
Australia | AU$97.21 Million |
|
Abliva AB
ST:ABLI
|
Sweden | Skr11.86 Million |
|
Citizens Holding Company
NASDAQ:CIZN
|
USA | $1.45 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Flerie's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Flerie's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Flerie (2016–2025)
The table below shows the annual total liabilities of Flerie from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr20.30 Million | -19.76% |
| 2024-12-31 | Skr25.30 Million | -58.18% |
| 2023-12-31 | Skr60.50 Million | +248.18% |
| 2022-12-31 | Skr17.38 Million | +55.75% |
| 2021-12-31 | Skr11.16 Million | -5.90% |
| 2020-12-31 | Skr11.86 Million | -47.50% |
| 2019-12-31 | Skr22.58 Million | +2.99% |
| 2018-12-31 | Skr21.93 Million | -0.89% |
| 2017-12-31 | Skr22.12 Million | +30.03% |
| 2016-12-31 | Skr17.02 Million | -- |